Evidence map›Paper›PMID 32918820›Full record

ArticleEuropean journal of public health2020

Impact of the Tobacco Products Directive on self-reported exposure to e-cigarette advertising, promotion and sponsorship in smokers-findings from the EUREST-PLUS ITC Europe Surveys.

Sarah Kahnert, Pete Driezen, James Balmford, Christina N Kyriakos, Tibor Demjén, Esteve Fernández, Paraskevi A Katsaounou, Antigona C Trofor, Krzysztof Przewoźniak, Witold A Zatoński and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 16 institutions in 9 countries.

Sarah KahnertCancer Prevention Unit & WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pete DriezenDepartment of Psychology, University of Waterloo, Waterloo, ON, Canada.
James BalmfordInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany.
Christina N KyriakosEuropean Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium.
Tibor DemjénSmoking or Health Hungarian Foundation, Budapest, Hungary.
Esteve FernándezDepartment of Cancer Epidemiology and Prevention, Catalan Institute of Oncology (ICO), Barcelona, Spain.
Paraskevi A KatsaounouFirst ICU Evaggelismos Hospital Athens, National and Kapodistrian University of Athens, Athens, Greece.
Antigona C TroforUniversity of Medicine and Pharmacy 'Grigore T. Popa', Iasi, Romania.
Krzysztof PrzewoźniakHealth Promotion Foundation, Warsaw, Poland.
Witold A ZatońskiHealth Promotion Foundation, Warsaw, Poland.
Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, ON, Canada.
Constantine I VardavasEuropean Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium.
Ute MonsCancer Prevention Unit & WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany.
EUREST-PLUS Consortium
University of Crete · GRUniversity of Waterloo · CACentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESEuropean Respiratory Society · CHFoundation for Polish Science · PLGerman Cancer Research Center · DEGrigore T. Popa University of Medicine and Pharmacy · ROHungarian Institute of Occupational Health · HUUniwersytet Kaliski im. Prezydenta Stanisława Wojciechowskiego · PLCollegium Civitas · PLEuropean Network for Smoking and Tobacco Prevention · BEHeidelberg University · DENational and Kapodistrian University of Athens · GROntario Institute for Cancer Research · CAUniversity Hospital Heidelberg · DEUniversity of Freiburg · DE

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
NCI NIH HHS P01 CA200512
6 · The paper itself

Abstract

backgroundAdvertising, promotion and sponsorship of electronic cigarettes (ECAPS) have increased in recent years. Since May 2016, the Tobacco Products Directive 2014/40/EU (TPD2) prohibits ECAPS in various advertising channels, including media that have cross-border effects. The objective of this study was to investigate changes in exposure to ECAPS in a cohort of smokers from six European Union member states after implementation of TPD2.

methodsSelf-reported exposure to ECAPS overall and in various media and localities was examined over two International Tobacco Control Policy Evaluation survey waves (2016 and 2018) in a cohort of 6011 adult smokers from Germany, Greece, Hungary, Poland, Romania and Spain (EUREST-PLUS Project) using longitudinal generalized estimating equations models.

resultsSelf-reported ECAPS exposure at both timepoints varied between countries and across examined advertising channels. Overall, there was a significant increase in ECAPS exposure [adjusted odds ratio (aOR): 1.25, 95% CI: 1.09-1.44]. Between waves, no consistent patterns of change in ECAPS exposure across countries and different media were observed. Generally, ECAPS exposure tended to decline in some channels regulated by TPD2, particularly on television and radio, while exposure tended to increase in some unregulated channels, such as at points of sale.

conclusionsThe findings suggest that the TPD2 was generally effective in reducing ECAPS in regulated channels. Nonetheless, further research is warranted to evaluate its role in reducing ECAPS exposure, possibly by triangulation with additional sources of data.

Indexed as

Electronic Nicotine Delivery SystemsSelf ReportTobacco ProductsAdultAdvertisingEuropeGermanyGreeceHumansHungaryPolandRomaniaSmokersSpain

Identifiers

PMID32918820
PMCPMC7526780
OpenAlexW3086750737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.